Dr. Arjun Sahgal on a major advance for high-grade gliomas with adaptive online MR-guided radiation therapy
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Dr. Arjun Sahgal on a major advance for high-grade gliomas with adaptive online MR-guided radiation therapy
-
ナレーター：
-
著者：
このコンテンツについて
In this episode, Dr. Arjun Sahgal, an international clinical and research leader in the field of high-precision stereotactic radiation to the brain and spine for both metastases and primary tumors, as well as oligometastases and the chief of radiation oncology at Sunnybrook Health Sciences Centre’s Odette Cancer Centre, shares his excitement around the initial results of the UNITED (Unity-Based MR-Linac Guided Adaptive Radiotherapy for High Grade Glioma) trial. UNITED is the world’s first adaptive MR-guided radiotherapy study for patients with high-grade gliomas, the most common and aggressive primary brain tumors found in adults, and the highlight of his illustrious career so far.
Dr. Sahgal has made challenging the dogma and changing the standard of care for patients whose cancer is considered “incurable” his trademark. But what inspires him? Tune in to episode 2 of Spilling the RT to find out.